Curis to Present at the 2005 Bear Stearns Healthcare Conference

Business Wire, Sept 1, 2005

CAMBRIDGE, Mass. -- Headline should read: Curis to Present at the 2005 Bear Stearns Healthcare Conference (sted Curis to Present at the Bear Stearns Boston Biotech Confab)

The corrected release reads:

CURIS TO PRESENT AT THE 2005 BEAR STEARNS HEALTHCARE CONFERENCE

Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today announced that the Company will be presenting at the 2005 Bear Stearns Healthcare Conference on Monday, September 12, at the Grand Hyatt New York in New York City.

Daniel Passeri, Curis' President and Chief Executive Officer, will provide an overview of the status of Curis' business and collaborations at 11:30 a.m. Eastern. There will be an audio webcast of the presentation at:

http://customer.talkpoint.com/BEAR002/091205a_cy/ default.asp?entity=curis (Due to the length of this URL, it may be necessary to copy and paste it into your Internet browser's URL address field. You may also need to remove an extra space in the URL if one exists.)

The presentation will be archived shortly after the live event and available for 30 days following the conference. The presentation will also be available on the Investor Relations section of Curis' website at www.curis.com.

About Curis, Inc.

Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer (under collaboration with Genentech, which also includes a co-development arrangement for a basal cell carcinoma product candidate), kidney disease (licensed to Ortho Biotech Products and under development at Centocor, both subsidiaries of Johnson & Johnson), neurological disorders (under collaboration with Wyeth), hair growth, and cardiovascular disease. For more information, please visit the Curis web site at www.curis.com.